Selective serotonin reuptake inhibitors (SSRIs) are pharmaceuticals whose consumption
has increased significantly. They are prescribed as first-line treatment in mental disorders …

The global prevalence of depression has risen over the past three decades across all
socioeconomic groups and geographic regions, with a particularly rapid increase in …

Background Growing concerns about the impact of coronavirus disease 2019 (COVID-19)
will likely lead to increased mental health diagnoses and treatment. To provide a pre-COVID …

Purpose This register-based study examined the trajectories of depression or anxiety
disorder-related work disability during and following long-term psychotherapy and identified …

Background Socio-economic status (SES) has been linked to treatment outcomes for mental
health problems, whilst little to no literature has explored the effects of SES on access to …

International literature suggests that co-payment increases are associated with decreased
medicine use, although the effects depend on context. We examined the impact of a co …

Background: Aboriginal and Torres Strait Islander Australians have a relatively high
prevalence of multimorbidity requiring treatment with medications. This study examines …

Objective We examined the income gradient changes in the use of long-term rehabilitative
psychotherapy and psychotropic drug purchases in men and women during a 9-year follow …

Background Population-based surveys suggest that low socioeconomic status (SES) is
associated with higher prevalence of depressive symptoms, while their healthcare utilization …

ABSTRACT OBJECTIVE In recent decades there has been an increase in the use of
antidepressants (AD) and a decrease in the use of benzodiazepines (BDZ). Prevalence …